The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07761598

Acronym

FAST

Enrollment

Registered

2026-08-12

Start date

2026-08-01

Completion date

2028-12-01

Last updated

2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm Cerebral

Keywords

Aneurysm Cerebral, Stroke, Medical Device Treatment

Brief summary

The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) is a prospective, single-arm investigation.

Detailed description

The FAST study is an Early Feasibility Study (EFS), prospective, open-label, single-arm, unblinded, fifteen (n=15) patient investigation

Interventions

DEVICEFred X Medical Device Intervention for Aneurysm Treatment with DAPT Therapy.

medial device intervention for aneurysm cerebral.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

22 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Subject has a single untreated target IA.

Exclusion criteria

* Subject with anatomy not appropriate for endovascular treatment.

Design outcomes

Primary

Measure	Time frame	Description
A thromboembolic event in the territory supplied by the treated artery.	12 months	A thromboembolic event in the territory supplied by the treated artery.

Countries

United States

Contacts

CONTACTKevin MacDonald

kmacdonald@jacobsinstitute.org(716) 888-4814

PRINCIPAL_INVESTIGATORElad Dr. Levy, MD

Jacobs institute

CONTACTCarlos Dr. Pena, PhD

cpena@jacobsinstitute.org(716) 888-4814

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026